RU94046070A - Применение /(4-(1,4,5,6-тетрагидро-4-метил-6-оксо-3-пиридазинил)фенил)гидразоно/ пропандинитрила для лечения или профилактики ишемии миокарда, способ лечения ишемии миокарда - Google Patents

Применение /(4-(1,4,5,6-тетрагидро-4-метил-6-оксо-3-пиридазинил)фенил)гидразоно/ пропандинитрила для лечения или профилактики ишемии миокарда, способ лечения ишемии миокарда

Info

Publication number
RU94046070A
RU94046070A RU94046070/14A RU94046070A RU94046070A RU 94046070 A RU94046070 A RU 94046070A RU 94046070/14 A RU94046070/14 A RU 94046070/14A RU 94046070 A RU94046070 A RU 94046070A RU 94046070 A RU94046070 A RU 94046070A
Authority
RU
Russia
Prior art keywords
treatment
myocardium ischemia
propanedinitrile
hydrazono
pyridazinyl
Prior art date
Application number
RU94046070/14A
Other languages
English (en)
Other versions
RU2146142C1 (ru
Inventor
Олави Хайкала Хеймо
Fi]
Михаэль Левийоки Йуко
Йоханнес Бэкстрем Реййо
Тапио Норе Пентти
Юхани Хонканен Эркки
Original Assignee
Орион-Ихтюмя Ой (FI)
Орион-Ихтюмя Ой
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Орион-Ихтюмя Ой (FI), Орион-Ихтюмя Ой filed Critical Орион-Ихтюмя Ой (FI)
Publication of RU94046070A publication Critical patent/RU94046070A/ru
Application granted granted Critical
Publication of RU2146142C1 publication Critical patent/RU2146142C1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

[[4-(1,4,5,6-тетрагидро-4-метил-6-оксо-3- пиридазинил)-фенил]гидразоно] пропандинитрил, который ранее был предложен для лечения застойной сердечной недостаточности, полезен для лечения ишемии миокарда.

Claims (1)

  1. [[4-(1,4,5,6-тетрагидро-4-метил-6-оксо-3- пиридазинил)-фенил]гидразоно] пропандинитрил, который ранее был предложен для лечения застойной сердечной недостаточности, полезен для лечения ишемии миокарда.
RU94046070A 1992-05-06 1993-05-05 Применение [[4-(1,4,5,6-тетрагидро-4-метил-6-оксо-3-пиридазинил)фенил]-гидразоно] пропандинитрила для лечения или профилактики ишемии миокарда, способ лечения ишемии миокарда RU2146142C1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9209769.0 1992-05-06
GB9209769A GB2266841A (en) 1992-05-06 1992-05-06 Compounds for use as anti-ischemic medicaments
PCT/FI1993/000191 WO1993021921A1 (en) 1992-05-06 1993-05-05 Anti-ischemic medicament

Publications (2)

Publication Number Publication Date
RU94046070A true RU94046070A (ru) 1996-09-20
RU2146142C1 RU2146142C1 (ru) 2000-03-10

Family

ID=10715082

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94046070A RU2146142C1 (ru) 1992-05-06 1993-05-05 Применение [[4-(1,4,5,6-тетрагидро-4-метил-6-оксо-3-пиридазинил)фенил]-гидразоно] пропандинитрила для лечения или профилактики ишемии миокарда, способ лечения ишемии миокарда

Country Status (25)

Country Link
US (1) US5512572A (ru)
EP (1) EP0639074B1 (ru)
JP (2) JP3313714B2 (ru)
KR (1) KR100275823B1 (ru)
AT (1) ATE196086T1 (ru)
AU (1) AU665840B2 (ru)
BG (1) BG61678B1 (ru)
BR (1) BR9306314A (ru)
CA (1) CA2134972C (ru)
CZ (1) CZ283259B6 (ru)
DE (1) DE69329381T2 (ru)
DK (1) DK0639074T3 (ru)
ES (1) ES2150445T3 (ru)
FI (1) FI945052A (ru)
GB (1) GB2266841A (ru)
GR (1) GR3034896T3 (ru)
HU (1) HU222349B1 (ru)
NO (1) NO306236B1 (ru)
NZ (1) NZ252693A (ru)
PT (1) PT639074E (ru)
RO (1) RO115781B1 (ru)
RU (1) RU2146142C1 (ru)
SK (1) SK279580B6 (ru)
UA (1) UA35584C2 (ru)
WO (1) WO1993021921A1 (ru)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9614098D0 (en) 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan
FI973804A (fi) * 1997-09-26 1999-03-27 Orion Yhtymae Oy Levosimendaanin oraalisia koostumuksia
FI974578A (fi) 1997-12-19 1999-06-20 Orion Yhtymae Oyj Menetelmä levosimendaanin antamiseksi
FI980902A (fi) 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaanin stabiileja koostumuksia
FI980901A (fi) * 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaania säädellysti vapauttavia oraalisia koostumuksia
FI104718B (fi) * 1998-06-18 2000-03-31 Orion Yhtymae Oyj [[4-(2-atsido-3-metyyli-5-oksotetrahydrofuran-2-yyli)fenyyli]hydratsono]propaanidinitriili käytettäväksi referenssiaineena levosimendaanierien analyysissä
FI981473A (fi) * 1998-06-25 1999-12-26 Orion Yhtymae Oyj Menetelmä pulmonaalihypertension hoitamiseksi
GB9915179D0 (en) * 1999-06-29 1999-09-01 Orion Corp A method for the treatment or prevention of coronary graft vasospasm
FI109659B (fi) 1999-09-10 2002-09-30 Orion Yhtymae Oyj Levosimendaanin farmaseuttisia liuoksia
EP1248620B1 (en) 1999-10-22 2004-11-17 Orion Corporation A new use of levosimendan
FI20001542A (fi) 2000-06-29 2001-12-30 Orion Yhtymae Oyj Menetelmä septisen sokin hoitamiseksi
FI20002526A (fi) * 2000-11-17 2002-05-18 Orion Yhtymae Oyj Pyridatsinonijohdannaisten uusi käyttö
FI20002755A0 (fi) 2000-12-15 2000-12-15 Orion Yhtymae Oyj Menetelmä erektiilin dysfunktion hoitamiseen
JP2002211346A (ja) * 2001-01-15 2002-07-31 Takata Corp インフレータ
FI20010233A0 (fi) 2001-02-08 2001-02-08 Orion Corp Menetelmä sydämen vajaatoiminnan hoitoon
FI20020197A0 (fi) * 2002-02-01 2002-02-01 Orion Corp Yhdistelmä akuutin myokardiilisen infarktin hoitoon
US8618316B1 (en) 2004-03-05 2013-12-31 Stepan Company Low temperature ramp rate ester quat formation process
FI20040674A0 (fi) 2004-05-12 2004-05-12 Orion Corp Menetelmä tromboembolisten sairauksien estoon
FI20040675A0 (fi) * 2004-05-12 2004-05-12 Orion Corp Menetelmä sydämen hypertrofian hoitoon ja estoon
EP1758584A1 (en) * 2004-05-28 2007-03-07 Abbott Laboratories Methods for treating a mammal before, during and after cardiac arrest
WO2012093404A2 (en) 2011-01-03 2012-07-12 Gufic Biosciences Limited Parenteral formulations of levosimendan
CN105784895B (zh) * 2015-10-30 2018-05-22 成都欣捷高新技术开发有限公司 一种用高效液相色谱仪检测左西孟旦中杂质的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962110A (en) * 1985-03-12 1990-10-09 Smith Kline & French Laboratories Limited Pyridazinone derivatives
GB8603780D0 (en) * 1986-02-15 1986-03-19 Smith Kline French Lab Chemical compounds
GB8722776D0 (en) * 1987-09-28 1987-11-04 Smith Kline French Lab Chemical compounds
FI884418A (fi) * 1987-10-05 1989-04-06 Fujisawa Pharmaceutical Co Hjaertskyddande aemne och ett terapeutiskt aemne foer ischemiska sjukdomar omfattande n-innehaollande heterocykliska foereningar, och ett foerfarande foer framstaellning av dessa foereningar.
GB8903130D0 (en) * 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
US5109575A (en) * 1991-06-10 1992-05-05 Signode Corporation Toothed seal for hard thermoplastic strap

Also Published As

Publication number Publication date
JP2002275067A (ja) 2002-09-25
RU2146142C1 (ru) 2000-03-10
CA2134972A1 (en) 1993-11-11
HU222349B1 (hu) 2003-06-28
EP0639074A1 (en) 1995-02-22
RO115781B1 (ro) 2000-06-30
HUT68956A (en) 1995-08-28
KR950701223A (ko) 1995-03-23
GB2266841A (en) 1993-11-17
JPH07506354A (ja) 1995-07-13
FI945052A0 (fi) 1994-10-27
HU9403191D0 (en) 1995-02-28
BR9306314A (pt) 1998-06-30
FI945052A (fi) 1994-10-27
NO944145D0 (no) 1994-10-31
NO944145L (no) 1994-10-31
CZ283259B6 (cs) 1998-02-18
BG99164A (bg) 1995-08-28
UA35584C2 (ru) 2001-04-16
GR3034896T3 (en) 2001-02-28
US5512572A (en) 1996-04-30
NZ252693A (en) 1997-07-27
ES2150445T3 (es) 2000-12-01
JP3313714B2 (ja) 2002-08-12
ATE196086T1 (de) 2000-09-15
AU4262793A (en) 1993-11-29
AU665840B2 (en) 1996-01-18
NO306236B1 (no) 1999-10-11
GB9209769D0 (en) 1992-06-17
DE69329381T2 (de) 2001-04-26
SK132494A3 (en) 1995-11-08
EP0639074B1 (en) 2000-09-06
CA2134972C (en) 2004-07-20
CZ272094A3 (en) 1995-02-15
SK279580B6 (sk) 1999-01-11
DK0639074T3 (da) 2000-10-09
PT639074E (pt) 2001-03-30
WO1993021921A1 (en) 1993-11-11
KR100275823B1 (ko) 2001-03-02
BG61678B1 (bg) 1998-03-31
DE69329381D1 (de) 2000-10-12

Similar Documents

Publication Publication Date Title
RU94046070A (ru) Применение /(4-(1,4,5,6-тетрагидро-4-метил-6-оксо-3-пиридазинил)фенил)гидразоно/ пропандинитрила для лечения или профилактики ишемии миокарда, способ лечения ишемии миокарда
LV11174A (lv) (-)-ÚÚ4-(1,4,5,6-tetrahidro-4-metil-6-okso-3-piridazinil)fenil¾-hidrazono¾ propandinitrils
RU94031102A (ru) Сульфамиды в качестве антагонистов эндотелина и способ лечения соответствующих заболеваний
RS82003A (en) Anthranilic acid amides, method for the production thereof, their use as antiarhythmia agents, and pharmaceutical preparations thereof
TR200103701T2 (tr) İndanil ikameli benzolkarbonamidleri, imalat yöntemleri, ilaç olarak kullanımları
ATE147981T1 (de) Verabreichung von lamotrigin zur behandlung von neuro-aids
DE59308848D1 (de) Anwendung von urodilatin bei lungen- und bronchialerkrankungen
DE69726281D1 (de) Hemmstoff für die gefässneubildung, der den gewebefaktor-inhibitor (tfpi) enthält
DE69230790D1 (de) Arzneimittel zur Behandlung von durch Babesia verursachten Protozoeninfektionen
EP0645963A4 (ru)
SE9902269D0 (sv) Pharmaceutically active compounds
RU95108375A (ru) Способ профилактики и лечения коронарогенных повреждений миокарда

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20060506